Skip to main content
BSE - SMEListed
Cian Healthcare Limited Logo

Cian Healthcare Limited IPO

Cian Healthcare Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 62.00 (-4.62%)

Cian Healthcare Limited's achieved publicly listed status following its IPO debut on 23-05-2019 at the BSE platform. The offering successfully mobilized 62,16,000 Shares, with TBD allocated to corporate growth initiatives.

Investment participation occurred within the established price band of ₹61 to ₹65, starting from minimum lots of 2000 shares. The subscription window from 02-05-2019 through 15-05-2019 enabled investor participation across market segments.

Share allocation was completed on 20-05-2019, determining ownership distribution among successful applicants. The listing represents a milestone achievement, transitioning the company to regulated public market status with associated responsibilities and opportunities.

Cian Healthcare IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Cian Healthcare IPO Key Performance Indicator
Company Financials ( in Lakhs )

Cian Healthcare IPO About Company

Cian Healthcare Limited, incorporated in 2003, is a multinational manufacturing company certified by WHO-GMP and ISO 9001:2015, specializing in food supplements, sexual wellness, cosmeceuticals, nutraceuticals, ayurvedic, and pharmaceutical products. The company develops, manufactures, and commercializes products across 12 therapeutic divisions and 10 sales divisions, operating under its own brand while also engaging in government supplies, exports, and third-party manufacturing. Its product portfolio includes sachets, gels, lotions, creams, ointments, liquid orals, capsules, and tablets, and it holds a special license to manufacture veterinary products such as Venky's and SAVAvet. As of March 31, 2018, sales were comprised of 37% contract manufacturing, 24% government supplies, 23% franchise business, and 16% export sales.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Cian Healthcare IPO Strength Factors

  1. Pan-India Presence: Operates across the country.
  2. Experienced Promoters: 15 years of industry expertise.
  3. Strong Purchasing Power: Effective sourcing capabilities.
  4. Robust Distribution: Well-established distribution network.
  5. Low-Cost Operations: Maintains cost-efficient business processes.

Cian Healthcare IPO Risk Factors

NA


Cian Healthcare IPO Lead Manager(s)

  • Fedex Securities Private Limited

Cian Healthcare IPO Promoter(s)

  1. Mr. Suraj Zanwar
  2. Mrs. Kavita Zanwar

Cian Healthcare IPO Company Details

Cian Healthcare Limited
Phone:
address:

Cian Healthcare IPO Registrar

Bigshare Services Private Limited
Name:
Phone:

Cian Healthcare IPO FAQs